Business
Scancell Attendance at Upcoming Conferences
Scancell Attendance at Upcoming Conferences.
About this update from Scancell Holdings Plc
[{"type":"text","content":"\n\n12 March 2024\n \n \nScancell Holdings plc\n(\"Scancell\" or the \"Company\")\n \nScancell Announces its Attendance at Upcoming Conferences\n \nScancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, is pleased to confirm that it will be presenting at, and will also attend, several upcoming conferences and events. Presentations at these high-profile conferences follow the significant recent progress that Scancell has made in both pre-clinical and clinical development.\n \nThese include:\n \n· 14th World ADC taking place in London, UK from 12-15 March.\nMandeep Sehmi, Head of Business Development, will be presenting at the conference.\nTitle: Glymab ADC for targeting cancers with high unmet need\nDate and Time: Wednesday 13th March 5pm GMT\n \n· Oxford Global - Biologics 2024 taking place in London, UK from 13-15 March\nPoonam Vagehla and Foram Dave, Scientists at Scancell, will be presenting at the conference.\nSession Title: Nextgen Multispecifics, Cell Engagers & Other New Modalities\nTitle: Glycan Targeting Antibodies for T Cell Redirection\nDate and Time: Friday 15th March at 3:10 pm GMT\n \n· BIO-Europe Spring in Barcelona, Spain from 18-20 March\nMandeep Sehmi, Head of Business Development and Mireille Vankemmelbeke, PI at Scancell will be attending the conference.\n \n· 21st CIMT Annual Meeting taking place in Mainz, Germany from 15-17 May\nSamantha Paston, Head of Translational Research, will be attending the conference.\n \nIf you would like to arrange a meeting with management, please contact [email protected].\n \n-ENDS-\n \n\n\n\n\nFor further information, please contact:\n\n\n\n\n\n\n\nScancell Holdings plc\n\n\n+44 (0) 20 3709 5700\n\n\n\n\nProfessor Lindy Durrant, CEO\n \nDr Jean-Michel Cosséry, Non-Executive Chairman\n \n\n\n\n\n\n\n\nStifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)\n\n\n+44 (0) 20 7710 7600\n\n\n\n\nNicholas Moore/Samira Essebiyea (Healthcare Investment Banking)\n\n\n \n\n\n\n\nNick Adams/Nick Harland (Corporate Broking)\n \n\n\n \n\n\n\n\nWG Partners LLP (Joint Broker)\n\n\n+44 (0...